About: Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors. The company's lead product candidate is the PLN-101095, an oral, small molecule dual inhibitor of avß8 and avß1 integrins that is in Phase 1a/1b for the treatment of solid tumors. It is also developing drug discovery platform comprising proprietary library of over 15,000 integrin binding molecules, focusing on integrin-based target-mediated drug delivery. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.97 (-2.13%)
PLRX NASDAQ Pliant Therapeutics Inc
Pliant Therapeutics Inc share price
PLRX price activity
Last Price
$0.970
Change (24hr)
-0.02 USD (-2.13%)
Volume
116.39K
Volume (4w avg)
-
Open
$0.98
Day Range
$0.97 - $0.98
Previous Close
$0.99
Last Trade
13 Oct, 6:03 pm GMT+0
Delayed
13 Oct, 6:03 pm GMT+0
PLRX price performance
Delayed
13 Oct, 6:03 pm GMT+0
PLRX Market Signals